WT1 IgG antibody as a biomarker for WT1 peptide vaccine cancer immunotherapy

Japan Journal of Molecular Tumor Marker Research

Online ISSN : 2433-8575

WT1 IgG antibody as a biomarker for WT1 peptide vaccine cancer immunotherapy

Yusuke Oji, Sumiyuki Nishida, Rin Imanishi, Sayaka Ikejima, Mizuki Kanegae, Shouq Alzaaqi, Jun Nakata, Naoki Hosen, Akihiro Tsuboi, Yoshihiro Oka, Haruo Sugiyama

Author information

Yusuke Oji
Osaka Univ. Grad. Sch. Med.,Func. Diag. Sci.
Sumiyuki Nishida
Osaka Univ. Grad. Sch. Med.,Resp. Med. Clin. Immunol.
Rin Imanishi
Osaka Univ. Grad. Sch. Med.,Func. Diag. Sci.
Sayaka Ikejima
Osaka Univ. Grad. Sch. Med.,Func. Diag. Sci.
Mizuki Kanegae
Osaka Univ. Grad. Sch. Med.,Func. Diag. Sci.
Shouq Alzaaqi
Osaka Univ. Grad. Sch. Med.,Func. Diag. Sci.
Jun Nakata
Osaka Univ. Grad. Sch. Med.,Bioinformatics
Naoki Hosen
Osaka Univ. Grad. Sch. Med.,Cancer Stem Cell Biol.
Akihiro Tsuboi
Osaka Univ. Grad. Sch. Med.,Cancer Immunol.
Yoshihiro Oka
Osaka Univ. Grad. Sch. Med.,Cancer Stem Cell Biol.
Haruo Sugiyama
Osaka Univ. Grad. Sch. Med.,Cancer Immunol.

JOURNAL FREE ACCESS

2019 Volume 35 Pages 39-40

DOI https://doi.org/10.11241/jsmtmr.35.39

Details

Article 1st page

Content from these authors

Favorites & Alerts

Related articles

Recently viewed articles

Top